{
    "xml": "<topic id=\"PHP81669\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/adcortyl-intra-articularintradermal\" basename=\"adcortyl-intra-articularintradermal\" title=\"Adcortyl intra-articular/intradermal\">\n<title>Adcortyl<tm tmtype=\"reg\"/> intra-articular/intradermal</title>\n<topic id=\"PHP83939\" outputclass=\"indicationsAndDose\" rev=\"1.31\" parent=\"/clinical-medicinal-product-information/adcortyl-intra-articularintradermal\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Local inflammation of joints and soft tissues</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intra-articular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2.5&#8211;15&#8239;mg, adjusted according to size (for larger doses use <i>Kenalog</i>\n<tm tmtype=\"reg\"/>). Where appropriate dose may be repeated when relapse occurs, for details consult product literature.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intradermal injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2&#8211;3&#8239;mg, max. 5&#8239;mg at any one site (total max. 30&#8239;mg). Where appropriate may be repeated at intervals of 1&#8211;2 weeks, for details consult product literature.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP81669",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/adcortyl-intra-articularintradermal",
    "basename": "adcortyl-intra-articularintradermal",
    "title": "Adcortyl intra-articular/intradermal",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Local inflammation of joints and soft tissues",
                        "html": "Local inflammation of joints and soft tissues"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intradermal injection"
                    ],
                    "textContent": "By intradermal injection",
                    "html": "By intradermal injection"
                },
                "adult": [
                    {
                        "textContent": "2.5&#8211;15 mg, adjusted according to size (for larger doses use Kenalog ). Where appropriate dose may be repeated when relapse occurs, for details consult product literature.",
                        "html": "<p>2.5&#8211;15&#8239;mg, adjusted according to size (for larger doses use <i>Kenalog</i> <tm tmtype=\"reg\"/>). Where appropriate dose may be repeated when relapse occurs, for details consult product literature.</p>"
                    },
                    {
                        "textContent": "2&#8211;3 mg, max. 5 mg at any one site (total max. 30 mg). Where appropriate may be repeated at intervals of 1&#8211;2 weeks, for details consult product literature.",
                        "html": "<p>2&#8211;3&#8239;mg, max. 5&#8239;mg at any one site (total max. 30&#8239;mg). Where appropriate may be repeated at intervals of 1&#8211;2 weeks, for details consult product literature.</p>"
                    }
                ]
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}